RxDoctor Payments Data

Crystal Piras, DO

Family Medicine · Oakland, MDNPI 1841782901

Payments from drug & device makers

$396in general payments, 2019–2025

Across 22 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$62
  • Novo Nordisk$56
  • Abbott$55
  • Indivior Inc.$54
  • Merck$37
  • AstraZeneca$28
  • plus $104 from 6 others

What the payments were for

  • Food & beverage$396100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$396 in reported general payments places this provider in the 50th percentile of 1,193 family medicine providers in Maryland.

See all family medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$5,248
Medicare patients
148
Services billed
336

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide109$124,879
JardianceEmpagliflozin54$67,394
EliquisApixaban45$52,583
MounjaroTirzepatide30$32,544
FarxigaDapagliflozin Propanediol26$30,169
TrulicityDulaglutide25$24,596
Breo ElliptaFluticasone/Vilanterol25$15,310
JanuviaSitagliptin Phosphate12$14,193
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$13,862
Repatha SureclickEvolocumab11$12,515
Spiriva HandihalerTiotropium Bromide19$11,745
ShingrixVaricella-Zoster Ge/As01b/Pf58$10,889
Tresiba Flextouch U-100Insulin Degludec22$8,620
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15$8,073
Bevespi AerosphereGlycopyrrolate/Formoterol Fum11$7,155

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$56$124,879109 claims
Lilly USA, LLCMounjaro, Trulicity$15$57,14055 claims
PfizerEliquis, Dilantin$62$54,65757 claims
AstraZenecaFarxiga, Bevespi Aerosphere$28$37,32437 claims
MerckJanuvia$37$14,19312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,193 family medicine providers in Maryland.

Other family medicine in Oakland

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →